EVIO, Inc. (EVIO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 22, 2025, 4:00 PM EDT
EVIO, Inc. Market Cap
EVIO, Inc. has a market cap or net worth of $19.19 thousand as of August 25, 2025. Its market cap has decreased by -98.00% in one year.
Market Cap
19.19K
Enterprise Value
n/a
Revenue
2.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 3, 2014, EVIO, Inc.'s market cap has decreased from 72.54K to 19.19K, a decrease of -73.54%. That is a compound annual growth rate of -11.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 19.19K | - |
| Dec 31, 2024 | 19.19K | - |
| Dec 29, 2023 | 19.19K | 4.98% |
| Dec 30, 2022 | 18.28K | -99.30% |
| Dec 31, 2021 | 2.59M | 55.66% |
| Dec 31, 2020 | 1.67M | -24.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 632.06M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |